An endothelium-derived angiogenesis inhibitor vasohibin and its significance in tumor angiogenesis

研究成果: Article査読

抄録

Angiogenesis is regulated by a local balance between the levels of endogenous stimulators and inhibitors of angiogenesis. Understanding of the mechanism of angiogenesis has advanced significantly since the discovery of two members of the family of angiogenesis stimulators-vascular endothelial growth factor (VEGF) family proteins and angiopoietins. These factors act on endothelial cells to stimulate angiogenesis. In contrast, few genes encoding molecules that selectively inhibit angiogenesis have been discovered. We recently isolated a novel angiogenesis inhibitor, whose expression was augmented in endothelial cells by stimulation with VEGF. We named it vasohibin. Vasohibin is thought to be the first negative feedback regulator of angiogenesis, which is selectively expressed in endothelial cells.

本文言語English
ページ(範囲)s69-s72
ジャーナルCancer Chemotherapy and Pharmacology
58
SUPPL.
DOI
出版ステータスPublished - 2006 11月

ASJC Scopus subject areas

  • 腫瘍学
  • 毒物学
  • 薬理学
  • 癌研究
  • 薬理学(医学)

フィンガープリント

「An endothelium-derived angiogenesis inhibitor vasohibin and its significance in tumor angiogenesis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル